• English
  • Deutsch
  • Log In
    Password Login
    Research Outputs
    Fundings & Projects
    Researchers
    Institutes
    Statistics
Repository logo
Fraunhofer-Gesellschaft
  1. Home
  2. Fraunhofer-Gesellschaft
  3. Scopus
  4. S3 Guideline for the Treatment of Psoriasis vulgaris, adapted from EuroGuiDerm – part 2: Specific clinical and comorbid situations
 
  • Details
  • Full
Options
2026
Journal Article
Title

S3 Guideline for the Treatment of Psoriasis vulgaris, adapted from EuroGuiDerm – part 2: Specific clinical and comorbid situations

Abstract
The present Part 2 of the updated German S3 guideline on the treatment of psoriasis vulgaris provides recommendations for therapy selection in special clinical situations and in the presence of comorbidities. A major focus of this update is the chapter on screening for tuberculosis as well as therapy selection and management in latent tuberculosis. The recommendations regarding the use of interferon-gamma release assays and the indication for chest radiography have been extensively revised. In addition, the guidance on the suitability of systemic psoriasis therapies in patients with latent tuberculosis and on the need for preventive antituberculous treatment has been thoroughly updated. In the chapter on inflammatory bowel diseases, risankizumab and guselkumab have been added as recommended treatment options, as both agents have recently been approved for the indications Crohn's disease and ulcerative colitis. Further substantial revisions are included in the chapters on patients with a history of malignancy and viral hepatitis.
Author(s)
Nast, Alexander
Charité – Universitätsmedizin Berlin
Altenburg, Andreas
Städtisches Klinikum Dessau
Augustin, Matthias
Universitätsklinikum Hamburg-Eppendorf
Bachmann, Frank
Dermatology Center Berlin Siddi & Bachmann
Boehncke, Wolf Henning
Hôpitaux Universitaires de Genève
Cornberg, Markus
Hannover Medical School
Geerdes-Fenge, Hilte F.
Universität Rostock Uniklinikum und Medizinische Fakultät
Häcker, Brit
German Central Committee against Tuberculosis (DZK)
Härle, Peter
Marienhaus Clinic Mainz
Klaus, Joachim
German Psoriasis Federation
Köhm, Michaela
Fraunhofer-Institut für Translationale Medizin und Pharmakologie ITMP  
Köllner, Arno
Dermatology Office
Mrowietz, Ulrich
Universitätsklinikum Schleswig-Holstein Campus Kiel
Ockenfels, Hans Michael
Hospital Hanau
Pennitz, Antonia
Charité – Universitätsmedizin Berlin
Philipp, Sandra
Dermatology Office
Richter, Thomas
Helios Versorgungszentren GmbH
Rosenbach, Thomas
Dermatology Office
Schaberg, Tom
German Central Committee against Tuberculosis (DZK)
Schlaeger, Martin
Dermatology Office
Schmid-Ott, Gerhard
Berolina Klinik
Sebastian, Michael
Dermatology Office
Thölken, Karisa Farias Miksza
University Hospital Augsburg
von Kiedrowski, Ralph Michael
Dermatology Office
Willuhn, Uwe
German Psoriasis Federation
Zeyen, Christoph
Charité – Universitätsmedizin Berlin
Journal
Journal der Deutschen Dermatologischen Gesellschaft : JDDG  
Open Access
File(s)
Download (426.5 KB)
Rights
CC BY 4.0: Creative Commons Attribution
DOI
10.1111/ddg.16001
10.24406/publica-10093
Additional link
Full text
Language
English
Fraunhofer-Institut für Translationale Medizin und Pharmakologie ITMP  
Keyword(s)
  • Comorbidity

  • hepatitis

  • psoriasis

  • recommendations

  • tuberculosis

  • Cookie settings
  • Imprint
  • Privacy policy
  • Api
  • Contact
© 2024